Crinetics Pharmaceuticals, Inc.
CRNX
$84.70
$0.260.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.21B | 1.29B | 1.03B | 1.09B | 1.20B |
| Total Receivables | 11.96M | 5.68M | 592.00K | -- | -- |
| Inventory | 3.49M | 3.06M | 2.02M | -- | -- |
| Prepaid Expenses | 23.14M | 22.36M | 17.84M | 28.48M | 20.40M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 500.00K | 500.00K |
| Total Current Assets | 1.24B | 1.32B | 1.05B | 1.12B | 1.22B |
|
|
|||||
| Total Current Assets | 1.24B | 1.32B | 1.05B | 1.12B | 1.22B |
| Net Property, Plant & Equipment | 52.18M | 53.29M | 54.79M | 55.52M | 56.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 25.34M | 25.62M | 21.13M | 19.23M | 15.74M |
| Total Assets | 1.32B | 1.40B | 1.13B | 1.20B | 1.29B |
|
|
|||||
| Total Accounts Payable | 13.25M | 12.88M | 22.61M | 6.11M | 11.33M |
| Total Accrued Expenses | 58.41M | 50.40M | 54.74M | 59.96M | 48.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.59M | 6.54M | 6.49M | 6.44M | 6.61M |
| Total Finance Division Other Current Liabilities | 1.67M | 1.27M | 1.24M | 1.64M | 1.90M |
| Total Other Current Liabilities | 1.67M | 1.27M | 1.24M | 1.64M | 1.90M |
| Total Current Liabilities | 79.92M | 71.09M | 85.07M | 74.16M | 68.40M |
|
|
|||||
| Total Current Liabilities | 79.92M | 71.09M | 85.07M | 74.16M | 68.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 40.61M | 41.32M | 42.05M | 42.70M | 43.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.40M | 8.27M | 7.05M | 7.00M | 6.33M |
| Total Liabilities | 129.92M | 120.68M | 134.17M | 123.86M | 118.05M |
|
|
|||||
| Common Stock & APIC | 2.86B | 2.83B | 2.41B | 2.36B | 2.33B |
| Retained Earnings | -1.67B | -1.55B | -1.42B | -1.29B | -1.16B |
| Treasury Stock & Other | -4.27M | -2.29M | 1.75M | 2.08M | 1.51M |
| Total Common Equity | 1.19B | 1.28B | 992.08M | 1.07B | 1.17B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.19B | 1.28B | 992.08M | 1.07B | 1.17B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.19B | 1.28B | 992.08M | 1.07B | 1.17B |
|
|
|||||